Matthew Caufield
Stock Analyst at HC Wainwright & Co.
(0.70)
# 2,974
Out of 4,435 analysts
63
Total ratings
20.97%
Success rate
-25.62%
Average return
Main Sectors:
12 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EYEN Eyenovia | Reiterates: Buy | $12 | $0.81 | +1,385.15% | 10 | May 16, 2024 | |
| OPTN OptiNose | Reiterates: Buy | $5 | $1.08 | +362.96% | 4 | May 15, 2024 | |
| OCUP Ocuphire Pharma | Reiterates: Buy | $20 | $1.68 | +1,090.48% | 8 | May 13, 2024 | |
| FDMT 4D Molecular Therapeutics | Reiterates: Buy | $36 | $23.97 | +50.19% | 11 | May 13, 2024 | |
| PHAT Phathom Pharmaceuticals | Reiterates: Buy | $28 | $9.42 | +197.24% | 4 | May 10, 2024 | |
| HLVX HilleVax | Reiterates: Buy | $28 | $12.14 | +130.64% | 3 | May 10, 2024 | |
| ADVM Adverum Biotechnologies | Reiterates: Buy | $30 | $7.92 | +278.79% | 2 | May 10, 2024 | |
| LYRA Lyra Therapeutics | Downgrades: Neutral | $2 | $0.33 | +509.76% | 5 | May 7, 2024 | |
| ALDX Aldeyra Therapeutics | Reiterates: Buy | $10 | $3.86 | +159.07% | 8 | May 6, 2024 | |
| UBX Unity Biotechnology | Reiterates: Buy | $10 | $1.55 | +545.16% | 4 | Nov 14, 2023 | |
| FN Fabrinet | Reiterates: Buy | $28 | $239.53 | -88.31% | 1 | Aug 22, 2023 | |
| OPT Opthea | Reiterates: Buy | $14 | $2.84 | +392.96% | 3 | Aug 1, 2023 |
Eyenovia
May 16, 2024
Reiterates: Buy
Price Target: $12
Current: $0.81
Upside: +1,385.15%
OptiNose
May 15, 2024
Reiterates: Buy
Price Target: $5
Current: $1.08
Upside: +362.96%
Ocuphire Pharma
May 13, 2024
Reiterates: Buy
Price Target: $20
Current: $1.68
Upside: +1,090.48%
4D Molecular Therapeutics
May 13, 2024
Reiterates: Buy
Price Target: $36
Current: $23.97
Upside: +50.19%
Phathom Pharmaceuticals
May 10, 2024
Reiterates: Buy
Price Target: $28
Current: $9.42
Upside: +197.24%
HilleVax
May 10, 2024
Reiterates: Buy
Price Target: $28
Current: $12.14
Upside: +130.64%
Adverum Biotechnologies
May 10, 2024
Reiterates: Buy
Price Target: $30
Current: $7.92
Upside: +278.79%
Lyra Therapeutics
May 7, 2024
Downgrades: Neutral
Price Target: $2
Current: $0.33
Upside: +509.76%
Aldeyra Therapeutics
May 6, 2024
Reiterates: Buy
Price Target: $10
Current: $3.86
Upside: +159.07%
Unity Biotechnology
Nov 14, 2023
Reiterates: Buy
Price Target: $10
Current: $1.55
Upside: +545.16%
Fabrinet
Aug 22, 2023
Reiterates: Buy
Price Target: $28
Current: $239.53
Upside: -88.31%
Opthea
Aug 1, 2023
Reiterates: Buy
Price Target: $14
Current: $2.84
Upside: +392.96%